DoD Kidney Cancer, Postdoctoral and Clinical Fellowship Award
ID: 355137Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355137
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Kidney Cancer Research Program (KCRP) Postdoctoral and Clinical Fellowship Award to support innovative kidney cancer research. This grant aims to assist recent doctoral or medical school graduates in conducting high-impact research that has the potential to significantly advance kidney cancer treatment and patient care, with a focus on developing independent careers in this field. The program encourages applications that address strategic goals such as understanding kidney cancer biology and improving patient outcomes, particularly for active-duty Service Members and Veterans. Interested applicants must submit a pre-application letter of intent by August 15, 2024, with full applications due by September 5, 2024. The total estimated funding for this initiative is approximately $2.18 million, with individual awards not exceeding $195,000 over a maximum three-year period. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524KCRPPCFA_GG_Final.pdf
    The Department of Defense (DOD) is announcing the FY24 Kidney Cancer Postdoctoral and Clinical Fellowship Award, aimed at fostering innovative kidney cancer research through funding of up to $195,000 over a maximum three-year period. This program invites applications from recent graduates for projects that show substantial potential impact on kidney cancer patient care and research. Key submission dates include a required pre-application letter of intent by August 15, 2024, with full applications due September 5, 2024. The initiative seeks research that addresses strategic goals such as understanding kidney cancer biology, developing new therapeutic strategies, and improving patient outcomes, specifically targeting active-duty Service Members, Veterans, and the general public. Eligible applicants include both domestic and international organizations, with a focus on postdoctoral researchers in relevant fields. The review process includes peer evaluations and programmatic assessments to ensure alignment with DOD priorities. Ultimately, funding is contingent on available resources, application quality, and potential impact, emphasizing a collaborative approach to advancing kidney cancer research.
    KCRP_FY24_PCFA_Academic.pdf
    The document outlines the requirements for the Academic Statement component of the Department of Defense's Fiscal Year 2024 Kidney Cancer Research Program's Postdoctoral and Clinical Fellowship Award application. It serves to provide an alternative assessment of a Principal Investigator's (PI's) academic performance when official transcripts are unavailable. Key details requested include the organization attended, degree earned, date of degree completion, overall GPA or academic ranking, and additional information validating the PI's academic record, such as completed courses and honors. The document culminates with an official certifying the accuracy of the provided information through a signature section. The primary purpose of this statement is to ensure evaluators can assess the academic qualifications of applicants in circumstances where traditional documentation cannot be supplied, thereby maintaining the integrity of the application process within the framework of government grants and funding opportunities.
    Similar Opportunities
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at fostering diversity within the cancer research workforce. This grant supports clinical scientists with doctoral degrees who are underrepresented in health-related research, providing salary support for a 3-5 year period to gain intensive research training in various cancer research fields, particularly focusing on health disparities. The program is designed to enhance the research capabilities of awardees, preparing them for independent research careers in basic biomedical, behavioral, or translational cancer research. Interested applicants should note that the application period opens on January 12, 2025, with a submission deadline of February 12, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-320.html.
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at training individuals with clinical doctoral degrees for impactful careers in health-related research, particularly in cancer studies. This program is designed to support individuals from underrepresented backgrounds in health-related sciences, providing them with a mentored research career development experience over a period of 3 to 5 years, focusing on biomedical, behavioral, and clinical research, including clinical trials. Successful applicants are expected to commit at least 75% of their time to the project and will receive funding for salary and research-related expenses, with applications due at specific intervals starting January 12, 2025. For further information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-319.html.
    NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22), aimed at supporting diverse candidates transitioning from postdoctoral roles to independent research positions in cancer research. This grant provides financial support for up to three years, covering salary and research costs, specifically targeting senior postdoctoral fellows and individuals in equivalent positions who have completed relevant training and hold early-stage investigator status. The initiative emphasizes the importance of diversity in the biomedical workforce, encouraging applications from underrepresented groups, while stipulating that candidates cannot lead their own clinical trials but may participate in trials led by mentors. Interested applicants should note that the application deadline is January 7, 2028, and can find further details and guidelines in the full announcement available at NIH Grants. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) to support exceptional graduate students transitioning into postdoctoral roles focused on Kidney, Urology, or Hematology (KUH) research. This funding opportunity aims to recruit talented individuals from diverse fields such as engineering, data science, and genetics, while excluding those already engaged in KUH research. The program provides funding for up to two years for dissertation research (F99 phase) and four years of mentored postdoctoral training (K00 phase), with stipends, tuition, and allowances for living costs. Interested applicants must adhere to specific eligibility criteria and are encouraged to contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries. The application deadline is April 1, 2025, and further details can be found at the provided link: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-21-033.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32 � Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity for the NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32), specifically for early postdoctoral fellows in cancer research. This grant aims to enhance the pool of qualified individuals committed to addressing health-related research needs in the nation, particularly focusing on candidates from diverse backgrounds, including those underrepresented in the field. The program supports research training and requires applicants to identify a postdoctoral mentor and establish a comprehensive research and training plan prior to or shortly after beginning their postdoctoral research. The estimated synopsis post date is April 1, 2025, with applications due by June 12, 2025, and the anticipated award date is March 1, 2026. There is no cost-sharing or matching requirement for this discretionary grant, which falls under CFDA number 93.398.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows into independent faculty positions in cancer research. This grant program is designed for researchers with doctoral degrees who require minimal additional mentored training, providing up to two years of support during the K99 phase followed by up to three years of independent research funding in the R00 phase. The initiative underscores NIH's commitment to strengthening the workforce in cancer research, particularly in areas such as cancer control and prevention, while ensuring that applicants present a comprehensive career development plan and mentorship strategy. Applications will open on January 14, 2024, with potential awards beginning in February 2024; interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award (K99/R00), a federal grant designed to support postdoctoral researchers transitioning to independent faculty positions in cancer research. This program provides funding for up to five years, consisting of a two-year mentored phase (K99) followed by up to three years of independent research support (R00), contingent upon securing a tenure-track position. The initiative aims to foster a diverse and skilled workforce in biomedical research, addressing critical health needs while promoting the career development of emerging investigators. Interested applicants must hold a clinical or research doctorate and have no more than six years of postdoctoral experience at the time of application. The application period opens on January 13, 2025, with a submission deadline of October 14, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-135.html.
    NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Mentored Clinical Scientist Research Career Development Award (K08), aimed at enhancing diversity within the cancer research workforce. This grant supports individuals from underrepresented backgrounds with clinical doctoral degrees, providing them with an intensive, mentored research experience over a period of 3-5 years, focused on biomedical, behavioral, and translational cancer research. The program is critical for developing the skills necessary to lead independent clinical trials and to prepare awardees for competitive research project grants, addressing significant health disparities in cancer research. Interested applicants must submit their proposals by January 7, 2025, and can find additional information at NIH Grants. For inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Institutional Network Award (U2C) to enhance training in kidney, urologic, and hematologic research. This funding opportunity aims to foster a collaborative environment by inviting institutions to submit a unified application that supports a cohort of trainees and early-career investigators, with a strong emphasis on partnerships among institutions within metropolitan areas. The initiative is crucial for reshaping research training and promoting scientific collaboration, ensuring that the next generation of researchers is equipped to address complex biomedical challenges. Applications will be accepted starting October 16, 2023, with a submission deadline of September 27, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Mentored Clinical Scientist Research Career Development Award (K08) to promote diversity in cancer research. This grant is aimed at individuals with clinical doctoral degrees from underrepresented backgrounds, providing them with protected research time and mentorship to enhance their capabilities in basic, behavioral, and translational cancer research. The program is designed to cultivate a diverse pool of qualified researchers to address the nation's health research needs and reduce disparities in cancer care and outcomes, with a maximum award duration of five years and a commitment of at least 75% of the candidate's time to career development activities. Interested applicants must submit their proposals by January 7, 2025, and can find additional information at the NIH grants website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries.